Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Clinical trial NCT02128958 · COMPLETED
Trial details
- NCT number
- NCT02128958
- Sponsor
- Can-Fite BioPharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-11-27
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.